To sum up, the assayed endothelial dysfunction markers proved the presence of inflammatory condition in the endothelium, which was already at the very early stages of the disease, i.e., from the time of its diagnosis, when the inflammation marker (CRP) was not yet elevated. The gene discussed is CRP; the disease is endothelial dysfunction.